Objective
Background: The projected steep rise in global dementia prevalence will largely occur in low and middle-income countries (LMIC) and vulnerable populations in high-income countries (HIC). Up to 30% of all dementia is attributable to potentially modifiable risk factors. Mobile Health (mHealth) technology allows for scalable and widely implementable prevention programs using self-management for improvement of dementia risk factors.
Objective: To make dementia prevention strategies accessible to populations in LMIC and vulnerable populations in HIC using mobile health technology.
Methods: For this implementation project we will build upon the operational ‘Healthy Ageing Through Internet Counselling in the Elderly’ eHealth platform for self-management of risk factors for dementia and cardiovascular disease. Within vulnerable populations in HIC and in LMIC we will assess barriers and facilitators to adapt the existing eHealth platform to a culturally appropriate mHealth (smartphone) platform for self-management of dementia risk factors.
We will use a blended care approach with participants receiving remote personalized support by a health coach to improve their lifestyle and actively reduce their risk of dementia. The adapted mHealth platform will be evaluated in a randomised implementation trial in 2400 older people at increased risk of dementia in China and a vulnerable population with low SES in UK. Main outcomes are implementation outcomes such as acceptability, feasibility and sustainability of our mHealth intervention, costs, and effectiveness on dementia risk reduction
Relevance and impact
PRODEMOS addresses the HCO-07 call by building on an existing eHealth intervention that will be adapted to an mHealth platform for dementia prevention, specifically tailored to vulnerable populations in HIC and LMIC, and will be implemented in multiple settings to pave the way towards a scalable, global strategy for dementia risk reduction.
Fields of science
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health scienceshealth sciencespublic health
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesbasic medicineneurologydementia
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
1105AZ Amsterdam
Netherlands
See on map
Participants (8)
CB2 1TN Cambridge
See on map
Beijing
See on map
6718 TK Ede Gld
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
17177 Stockholm
See on map
75654 Paris
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
31052 Toulouse Cedex 3
See on map
1417 Luxembourg
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participation ended
BN1 9RH Brighton
See on map